Skip to main content
. 2019 Jun 13;11(1):142–150. doi: 10.1111/jdi.13075

Figure 3.

Figure 3

Change in glycated hemoglobin (HbA1c) from baseline (last observation carried forward) over time in Chinese patients with type 2 diabetes who were treated with dulaglutide 1.5 mg, dulaglutide 0.75 mg or glimepiride. LSM, least‐squares mean; SE, standard error.